Insulet Corp. (PODD)
134.36
-0.37
(-0.27%)
USD |
NASDAQ |
Oct 07, 16:00
134.36
0.00 (0.00%)
After-Hours: 20:00
Insulet Enterprise Value : 9.757B for Oct. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 9.757B |
| October 05, 2026 | 9.819B |
| October 02, 2026 | 9.546B |
| October 01, 2026 | 9.484B |
| September 30, 2026 | 9.462B |
| September 29, 2026 | 9.626B |
| September 28, 2026 | 9.645B |
| September 25, 2026 | 9.854B |
| September 24, 2026 | 9.830B |
| September 23, 2026 | 9.879B |
| September 22, 2026 | 10.08B |
| September 21, 2026 | 10.16B |
| September 18, 2026 | 10.16B |
| September 17, 2026 | 10.23B |
| September 16, 2026 | 10.16B |
| September 15, 2026 | 10.07B |
| September 14, 2026 | 9.970B |
| September 11, 2026 | 9.565B |
| September 10, 2026 | 9.754B |
| September 09, 2026 | 9.978B |
| September 08, 2026 | 10.28B |
| September 04, 2026 | 10.64B |
| September 03, 2026 | 10.86B |
| September 02, 2026 | 10.69B |
| September 01, 2026 | 10.70B |
| Date | Value |
|---|---|
| August 31, 2026 | 10.72B |
| August 28, 2026 | 10.48B |
| August 27, 2026 | 10.36B |
| August 26, 2026 | 10.36B |
| August 25, 2026 | 10.33B |
| August 24, 2026 | 10.50B |
| August 21, 2026 | 10.69B |
| August 20, 2026 | 10.60B |
| August 19, 2026 | 10.92B |
| August 18, 2026 | 10.68B |
| August 17, 2026 | 10.10B |
| August 14, 2026 | 10.35B |
| August 13, 2026 | 10.57B |
| August 12, 2026 | 10.47B |
| August 11, 2026 | 10.45B |
| August 10, 2026 | 10.32B |
| August 07, 2026 | 10.20B |
| August 06, 2026 | 10.07B |
| August 05, 2026 | 9.655B |
| August 04, 2026 | 11.98B |
| August 03, 2026 | 12.18B |
| July 31, 2026 | 11.88B |
| July 30, 2026 | 11.90B |
| July 29, 2026 | 12.25B |
| July 28, 2026 | 12.03B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| DexCom, Inc. | 30.92B |
| Abbott Laboratories | 197.51B |
| Boston Scientific Corp. | 73.25B |
| PROCEPT BioRobotics Corp. | 851.98M |
| Globus Medical, Inc. | 9.778B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 95.00M |
| Revenue (Quarterly) | 801.70M |
| Total Expenses (Quarterly) | 706.70M |
| EPS Diluted (Quarterly) | 1.066 |
| Gross Profit Margin (Quarterly) | 72.56% |
| Profit Margin (Quarterly) | 11.85% |
| Earnings Yield | 3.75% |
| Operating Earnings Yield | 5.46% |
| Normalized Earnings Yield | 3.687 |